0 items USD 0.00Search
Your search for "qyresearch global kinase inhibitors cancer treatment consumption 2016 market research report" gave back 686518 results.
Small molecule inhibitors that block the actions of protein kinases and the associated signaling pathways can thus have significant impact The global...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR). The global mTOR Inhibitors market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Checkpoint Inhibitors for Treating Cancer market size was valued at USD 12850 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). The global Nilotinib market is projected to reach US$ 1200.7...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Enzyme Inhibitors market size was valued at US$ 140620 million in 2023. With growing demand in downstream market, the Enzyme Inhibitors is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global BTK Inhibitor market size is expected to reach $ 1825.9 million by 2029, rising at a market growth of 10.4% CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Checkpoint Kinase 2 (CHEK2) Antibody is a specific antibody against CHEK2 protein. The global Checkpoint Kinase 2 (CHEK2) Antibody market is...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Bruton's Tyrosine Kinase (BTK) Inhibitors market size was valued at USD 9330.3 million in 2023 and is forecast to a readjusted size...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Kinase Inhibitor Small Molecule Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
